代谢学和痴呆风险:对前性研究的系统审查
Ashley C Flores1, Xinyuan Zhang2, Penny M Kris-Etherton1
1Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA, United States.
The Journal of nutrition
|January 14, 2024
概括
这一系统性审查发现,各种代谢物,如氨基酸和脂肪酸,与痴呆风险有关. 识别这些早期代谢物标记可能会改善痴呆症风险预测.
科学领域:
- 神经科学是一个神经科学.
- 代谢学 代谢学 代谢学
- 流行病学 流行病学
背景情况:
- 痴呆症患病率的增加需要了解其原因和进展.
- 在临床前或临床前阶段早期识别痴呆症生物标志物对于风险预测至关重要.
- 在前性研究中,对预诊断样本的代谢分析为发现潜在的疾病生物标志物提供了一条途径.
研究的目的:
- 系统地审查有关代谢物标志物与痴呆风险之间的关联现有证据.
- 总结人类研究的结果,以前性设计,包括痴呆症亚型.
主要方法:
- 在PubMed,PsycINFO和Web of Science数据库中进行了系统的文献搜索.
- 该审查包括13项前性研究,随访期从2.1年到21.0年不等.
- 分析了数据,以总结各种代谢物与痴呆风险之间的调整关联.
主要成果:
- 一些代谢物,包括氨基酸,脂肪酸,酸,脂质,脂蛋白和激素,与患痴呆症的风险增加有关.
- 审查确定了与痴呆症发病相关的额外代谢物标志物.
- 由于研究异质性和潜在的偏见,研究结果应谨慎解释.
结论:
- 本系统性审查通过总结潜在的关联,有助于理解代谢学与痴呆症之间的联系.
- 鉴定的代谢物标志物可能会提高对痴呆症病因学的理解.
- 需要进一步的精心设计的前性研究来证实研究结果和标准化方法.
更多相关视频
07:11Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
Published on: November 10, 2023
2.4K
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
7.8K
相关概念视频
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
